Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was TRY 663.12 million compared to TRY 510.5 million a year ago. Net income was TRY 58.18 million compared to TRY 64.29 million a year ago. Basic earnings per share from continuing operations was TRY 0.36 compared to TRY 0.397 a year ago.